PCOS Officially Renamed to PMOS to Reflect Hormonal Complexity

In a historic shift for women’s health, Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). The announcement was made on Tuesday, May 12, 2026, during the 28th European Congress of Endocrinology in Prague and published in the medical journal The Lancet. This change is the result of a 14-year global effort involving more than 50 professional and patient organizations aimed at correcting a name that experts say has been "misleading and harmful" for decades.

The new name, PMOS, was chosen to better represent the condition as a complex, whole-body hormonal and metabolic disorder rather than just a gynecological issue. Experts pointed out that the word "polycystic" often led to confusion because the "cysts" seen on ultrasounds are actually immature follicles, not pathological cysts. Furthermore, many women diagnosed with the condition never develop these follicles at all. By leading with "Polyendocrine" and "Metabolic," the new terminology highlights that the condition involves multiple hormone systems—such as insulin and androgens—and carries significant long-term risks for diabetes and heart health.

What the New Name Means:

• Polyendocrine: Acknowledges that multiple hormones (like insulin and testosterone) are interacting dysfunctionally.
• Metabolic: Highlights the central role of insulin resistance and its impact on weight, energy, and cardiovascular health.
• Ovarian: Recognizes that while the ovaries are affected, they are often the "downstream" victim of broader hormonal imbalances.
• Syndrome: Reflects that symptoms vary widely from person to person, including irregular cycles, acne, hair thinning, and mental health challenges.

A three-year transition period is now underway to update medical textbooks, electronic health records, and government health systems worldwide. The goal is for the name PMOS to be fully implemented in the 2028 International Guideline update. Health advocates believe this change will lead to earlier diagnoses—which currently take an average of 12 years—and more personalized care that looks beyond just fertility to address a woman's overall well-being.

What do you think about the shift from PCOS to PMOS? Does the new name make more sense to you? Please drop your comments below!

Share to: